Padagis®, a Michigan-based leader in generic pharmaceuticals, announced today that the State of Michigan has added its over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg to the state's distribution ...

ACHV's cytisinicline shows best-in-class efficacy and safety for smoking cessation. Click here to find out why ACHV stock is ...

A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...

A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.

Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...

A panelist discusses how a prospective study demonstrated that twice-daily use of a nasal spray significantly improved tear ...

Ipratropium bromide nasal solution (Nasal Spray) 0.03% is indicated for the symptomatic relief of rhinorrhea associated with ...

Lupin launches Ipratropium Bromide nasal spray in US, bioequivalent to Atrovent. The product addresses rhinitis and targets a $63 million market opportunity.

Lupin has announced the launch of Ipratropium Bromide Nasal Solution (nasal spray) in two strengths in the United States.

Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...

During the Bourne Select Board meeting on Tuesday, July 1, the Opioid Settlement Advising Group, along with Health Director ...